These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 531386

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Value of the beta-morpholino-ethylic ester of niflumic acid in children].
    Vanegroo A, Foulard M.
    Lille Med; 1979 May; 24(5):418-20. PubMed ID: 502730
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Preliminary study of the therapeutic action and tolerance of niflumic acid in pediatric otorhinolaryngology].
    Traissac L, Roche JC.
    Rev Laryngol Otol Rhinol (Bord); 1977 May; 98(5-6):317-21. PubMed ID: 897412
    [No Abstract] [Full Text] [Related]

  • 5. [Niflumic acid in otorhynolaryngologic inflammation in childhood. Controlled study versus feprazone].
    Tarantino V, Stura M, Cremonesi G.
    Minerva Pediatr; 1985 Oct 31; 37(20):827-32. PubMed ID: 3912657
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical study of the beta-morpholinoethylester of niflumic acid in children's dentistry].
    Benoit P, Michelet FX, Benoit JP.
    Rev Odontostomatol Midi Fr; 1975 Oct 31; (4):249-61. PubMed ID: 1236592
    [No Abstract] [Full Text] [Related]

  • 8. [Use of an anti-inflammatory agent, well tolerated by children, in the O.R.L. surgery].
    Morgon AH, Dubreuil C.
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1978 Jun 31; 27(6):419-22. PubMed ID: 151729
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Comparative trial by double-blind method of a niflumic acid derivative and oxyphenbutazone in pediatric O. R. L].
    Traissac L, Roche JC.
    Rev Laryngol Otol Rhinol (Bord); 1979 Jun 31; 100(1-2):151-61. PubMed ID: 379941
    [No Abstract] [Full Text] [Related]

  • 11. [Reversible acute kidney failure during the treatment of ORL infections with niflumic acid].
    André JL, Hanesse B, Krier MJ, Trechot P.
    Arch Pediatr; 1995 Jul 31; 2(7):699-700. PubMed ID: 7663667
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Controlled clinical study on the use of morniflumate in the treatment of inflammatory-degenerative diseases of the locomotor system].
    Raffaetà G, Saponati G, Terzuoli A.
    G Clin Med; 1987 Oct 31; 68(10):507-13. PubMed ID: 3428515
    [No Abstract] [Full Text] [Related]

  • 14. [Value of niflumic acid in otorhinolaryngology].
    Portmann M, Pardes P.
    Rev Laryngol Otol Rhinol (Bord); 1968 Oct 31; 89(7):494-8. PubMed ID: 5715347
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Niflumic acid in cervicofacial pathology].
    Gaillard J, Quilichini H.
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac (1967); 1971 Nov 31; 20(9):1098-102. PubMed ID: 4257538
    [No Abstract] [Full Text] [Related]

  • 17. [Clamoxyl in infectious pathology in the ORL field (apropos of 40 cases)].
    Traissac L.
    Rev Laryngol Otol Rhinol (Bord); 1975 Nov 31; 96(1-2):93-8. PubMed ID: 1144965
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Experiences with niflumic acid in inflammatory glomerulopathies].
    Boeckle H, Oechslen D, Lüttgen F, Lindenmaier K.
    Arzneimittelforschung; 1975 Jan 31; 25(1):120-2. PubMed ID: 1173764
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.